In an industry known for pushing the bounds of human innovation, tech elites are now trying to push the bounds of their own bodies. The hot new biohacking trend is injectable peptides — similar to the ones found in GLP-1 medications like Ozempic. But these are not approved by the Food and Drug Administration.These gray-market peptides, largely from Chinese manufacturers, are being used by tech workers and founders. Not just to lose weight, but to optimize their health and performance in all manner of ways. “Marketplace Tech” host Meghan McCarty Carino speaks with independent journalist Jasmine Sun, who recently wrote about this for the New York Times.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Startups are betting on a legalized peptide market | 0 | 7 | 26-05-2026 |
| 2 | Beyond the Jab: The Surprising New Frontiers of GLP-1 Therapy | 0 | 14.13 | 24-07-2026 |
| 3 | What AI fitness apps can and can't do — for now | 0 | 5 | 04-02-2026 |
| 4 | Decoding the evidence on peptides, from topicals to longevity | 2 | 6 | 09-07-2026 |
| 5 | Bytes: Week in Review - Anthropic and the Pentagon face off, OpenAI teams up with consulting firms and Mac Mini moves to the U.S. | 0 | 5 | 27-02-2026 |
| 6 | Why SpaceX stock soared, then stumbled | 0 | 7 | 26-06-2026 |
| 7 | БАДам под Ozempic прописали выход в онлайн // Насколько опасны имитации препаратов для похудения | -2 | 7 | 26-06-2026 |
| 8 | If A GLP-1 Medication Has Changed Your Life For The Better, We Want To Hear About It | 0 | 5 | 10-07-2026 |
| 9 | People On GLP-1s Like Ozempic And Zepbound Are Sharing The Surprise Benefits They Never Saw Coming, And Some Of These Genuinely Surprised Me | 0 | 10.41 | 24-07-2026 |
| 10 | It's a tough time to break into cybersecurity | -2 | 5 | 15-06-2026 |